October 7, 2008

Google Logo Add Us On GoogleAdd SciAm

Open access publisher BioMed Central sold to Springer

By Ivan Oransky

Join Our Community of Science Lovers!

This article was published in Scientific American’s former blog network and reflects the views of the author, not necessarily those of Scientific American

Open access pioneer BioMed Central has been acquired by Springer, ScientificAmerican.com has learned.

Open access is the movement, recently bolstered by Congress, to make studies available for free online, instead of charging taxpayers who funded the research (and others) to read them. Many prominent scientists have backed it, signing on with BioMed Central and a non-profit open access publisher, the Public Library of Science.

BioMed Central publisher Matthew Cockerill announced the news in an email today to editors of BMC's journals.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Those in the open access movement had watched BioMed Central with keen interest. Founded in 2000, it was the first for-profit open access publisher and advocates feared that when the company was sold, its approach might change. But Cockerill assured editors that a BMC board of trustees "will continue to safeguard BioMed Central's open access policy in the future." Springer "has been notable...for its willingness to experiment with open access publishing," Cockerill said in a release circulated with the email to editors.

Read more about Science 2.0, which takes open access even further, with scientists publishing raw experimental results, here, and about an open access milestone in physics, here.

 

 

 

 

 

 

 

 

Ivan Oransky is editor in chief of Spectrum and a distinguished writer in residence at New York University's Arthur L. Carter Journalism Institute. He is a co-founder of Retraction Watch and a volunteer member of the board of directors of the PubPeer Foundation.

More by Ivan Oransky

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe